Applied BioCode Corporation

6598

KYG0488D1051

Biotechnology & Medical Research

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
20.65 ^TWD	-0.24%		-1.20%	-18.38%

15/04	Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	CI
21/03	Applied BioCode Announces CEO Changes	CI

Applied BioCode Corporation Announces Resignation of Craig Griz Adams as Sales Director

January 04, 2023 at 12:55 pm IST

Applied BioCode Corporation announced resignation of Craig Griz Adams as Sales Director due to personal career planning, effective January 4, 2023.

Latest news about Applied BioCode Corporation

Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15/04	CI
Applied BioCode Announces CEO Changes	22/03	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer	28/23/28	CI
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer	23/23/23	CI
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/23/28	CI
Applied BioCode Corporation Announces the Change of Representative of Institutional Director	14/23/14	CI
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use	12/23/12	CI
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries	08/23/08	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer	13/23/13	CI
Applied Biocode Corporation Announces Revenue Results for the Fourth Quarter and Full Year of 2022	27/23/27	CI
Applied BioCode Corporation Announces Resignation of Craig Griz Adams as Sales Director	04/23/04	CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Applied BioCode Corporation(TWSE:6598) dropped from S&P Global BMI Index	19/22/19	CI
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	29/22/29	CI
Applied Biocode Corporation Announces the Change of Sales Director	25/22/25	CI
Applied BioCode Corporation Announces the Change of Vice President of Operation	25/22/25	CI
Applied BioCode Corporation Announces Change of Sales Director	17/22/17	CI
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Applied BioCode Appoints Chris Bernard as Chief Executive Officer	24/22/24	CI

Chart Applied BioCode Corporation

Duration

Period

More charts

Applied BioCode Corp is a is a Taiwan-based company mainly engaged in the provision of automated multiple detection platforms, various application development of detection platforms, as well as the research, development and sale of infectious disease diagnostic reagents. The Company's main products include digital barcode magnetic beads (BMB), optical analyzers, in vitro diagnostic reagents and others. The Company sells in the United States, Europe and Asia markets.

Sector

Biotechnology & Medical Research

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

20.65 TWD

Average target price

22 TWD

Spread / Average Target

+6.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
APPLIED BIOCODE CORPORATION	-18.38%	52.58M
EXACT SCIENCES CORPORATION	-36.59%	9.2B
GUARDANT HEALTH, INC.	-3.96%	3.12B
IOVANCE BIOTHERAPEUTICS, INC.	+20.32%	2.8B
BGI GENOMICS CO., LTD.	-18.71%	2.07B
VERACYTE, INC.	-22.32%	1.59B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+65.19%	1.44B
CAREDX, INC	+35.00%	830M
SEEGENE, INC.	-7.42%	724M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-25.61%	507M

Bio Diagnostics & Testing